Conference Coverage

Update of Studies with a Melanoma Vaccine

Published in Vaccine Weekly, April 10th, 1995

Dr. Malcom S. Mitchell, a Professor of Medicine and the Director of the Center for Biological Therapy and Melanoma Research at the University of California at San Diego, La Jolla, California, presented an update of work done at his institution on melanoma vaccines at the American Cancer Society's 37th Science Writers Seminar, held March 26-29, 1995, in New Orleans, Louisiana.

He started by saying, "an important aspect of what I've researched is longevity. The fact is, that getting response to vaccine therapy and other kinds of biological therapy, the responding patient survives longer, and that is really the take home message I want you to understand. Unlike...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1995-04-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry